Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$6.82 - $17.8 $2.71 Million - $7.08 Million
-397,855 Reduced 15.71%
2,134,625 $16.3 Million
Q3 2021

Nov 12, 2021

SELL
$13.62 - $19.48 $1.28 Million - $1.83 Million
-93,993 Reduced 3.58%
2,532,480 $37.5 Million
Q2 2021

Aug 13, 2021

BUY
$16.94 - $19.89 $44.5 Million - $52.2 Million
2,626,473 New
2,626,473 $48.6 Million

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Alpha Wave Global, LP Portfolio

Follow Alpha Wave Global, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Wave Global, LP, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Wave Global, LP with notifications on news.